Circulation. Heart failure Journal

•  
• Overview
•  
• Identity
•  
• View All
•  

Overview

publication venue for

• Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction..  17:-. 2024
• Effect of Dapagliflozin on Accelerometer-Based Measures of Physical Activity in Patients With Heart Failure: An Analysis of the DETERMINE Trials..  17:-. 2024
• Risk Factors and Outcomes Associated With Heart Failure With Preserved and Reduced Ejection Fraction in People With Chronic Kidney Disease..  17:-. 2024
• Impact of Advanced Therapy Centers on Characteristics and Outcomes of Heart Failure Admissions..  17:-. 2024
• Multi-Ethnic Study of Atherosclerosis Early Heart Failure Study: Rationale, Design, and Baseline Characteristics..  17:-. 2024
• Neurocognitive Impairments and Their Improvement Following Exercise and Dietary Interventions in Older Patients With Heart Failure With Preserved Ejection Fraction..  17:-. 2023
• Longitudinal Trends in Donor and Recipient Risk Profile, and Clinical Outcomes, for Donation After Circulatory Death Heart Transplantation..  16:-. 2023
• Effect of Dapagliflozin on 6-Minute Walk Distance in Heart Failure With Preserved Ejection Fraction: PRESERVED-HF..  16:-. 2023
• Dapagliflozin Improves Heart Failure Symptoms and Physical Limitations Across the Full Range of Ejection Fraction: Pooled Patient-Level Analysis From DEFINE-HF and PRESERVED-HF Trials..  16:-. 2023
• Response by Brubaker et al to Letter Regarding "A Randomized, Controlled Trial of Resistance Training Added to Caloric Restriction Plus Aerobic Exercise Training in Obese Heart Failure With Preserved Ejection Fraction"..  16:-. 2023
• Improvement in Renal Function During the Treatment of Acute Decompensated Heart Failure: Relationship With Markers of Renal Tubular Injury and Prognostic Importance..  16:-. 2023
• Quality of Life Trajectory and Its Mediators in Older Patients With Acute Decompensated Heart Failure Receiving a Multi-Domain Rehabilitation Intervention: Results From the Rehabilitation Therapy in Older Acute Heart Failure Patients Trial..  15:-. 2022
• A Randomized, Controlled Trial of Resistance Training Added to Caloric Restriction Plus Aerobic Exercise Training in Obese Heart Failure With Preserved Ejection Fraction..  16:-. 2022
• Health of the Food Environment Is Associated With Heart Failure Mortality in the United States..  15:-. 2022
• Defining the Specific Skeletal Muscle Adaptations Responsible for Exercise Training Improvements in Heart Failure With Preserved Ejection Fraction..  15:-. 2022
• Sarcopenic Obesity Is Associated With Reduced Cardiorespiratory Fitness Compared With Nonsarcopenic Obesity in Patients With Heart Failure With Reduced Ejection Fraction..  15:-. 2022
• "Would You Get a Destination Therapy Left Ventricular Assist Device?": Health Care Workers' Views on a Preference-Sensitive Decision..  15:-. 2022
• Cardiogenic Shock From Heart Failure Versus Acute Myocardial Infarction: Clinical Characteristics, Hospital Course, and 1-Year Outcomes..  15:-. 2022
• Does Aspirin Prevent Incident Heart Failure in Healthy Older Adults? Examining the Evidence From the ASPREE Trial..  15:-. 2022
• "My Amazing Heart": A Patient's Simple Request to Change Outdated Heart Failure Labels..  15:-. 2022
• Social Determinants of Health and 30-Day Readmissions Among Adults Hospitalized for Heart Failure in the REGARDS Study..  15:-. 2021
• Incidence and Outcomes of Acute Heart Failure With Preserved Versus Reduced Ejection Fraction in SPRINT..  14:-. 2021
• Temporal Trends and Prognosis of Physical Examination Findings in Patients With Acute Decompensated Heart Failure: The ARIC Study Community Surveillance..  14:-. 2021
• FGF-23 (Fibroblast Growth Factor-23) and Cardiorenal Interactions..  14:-. 2021
• Clinical Characteristics and Outcomes of Adults With a History of Heart Failure Hospitalized for COVID-19..  14:-. 2021
• Psychometric Evaluation of the Kansas City Cardiomyopathy Questionnaire in Men and Women With Heart Failure..  14:-. 2021
• Acute Hemodynamic Effects and Tolerability of Phosphodiesterase-1 Inhibition With ITI-214 in Human Systolic Heart Failure..  14:-. 2021
• Untangling the Sex-Frailty Paradox in Heart Failure..  14:-. 2021
• Measured Versus Estimated Resting Metabolic Rate in Heart Failure With Preserved Ejection Fraction..  14:-. 2021
• Response by Unlu et al to Letter Regarding Article, "Polypharmacy in Older Adults Hospitalized for Heart Failure"..  14:-. 2021
• Ketone Ester Treatment Improves Cardiac Function and Reduces Pathologic Remodeling in Preclinical Models of Heart Failure..  14:-. 2020
• Polypharmacy in Older Adults Hospitalized for Heart Failure..  13:-. 2020
• Prognostic Awareness and Goals of Care Discussions Among Patients With Advanced Heart Failure..  13:-. 2020
• Letter by Tedford et al Regarding Article, "Effective Arterial Elastance in the Pulmonary Arterial Circulation: Derivation, Assumptions, and Clinical Applications"..  13:-. 2020
• "The Secret Life of Human Donor Hearts": An Examination of Transcriptomic Events During Cold Storage..  13:-. 2020
• Characteristics and Healthcare Utilization Among Veterans Treated for Heart Failure With Reduced Ejection Fraction Who Switched to Sacubitril/Valsartan..  12:-. 2019
• Identification of Racial Inequities in Access to Specialized Inpatient Heart Failure Care at an Academic Medical Center..  12:-. 2019
• HeartMate II System Controller Failure Presenting as Driveline Fault With Repeated Pump Stoppages..  12:-. 2019
• Response by Cappola and Cappola to Letter Regarding Article, "Thyroid Dysfunction in Heart Failure and Cardiovascular Outcomes"..  12:-. 2019
• Chronic Atrial and Ventricular Pacing in the Mouse..  12:-. 2019
• Don't Be Afraid: Using an ICD Means Having Difficult Conversations..  12:-. 2019
• Thyroid Dysfunction in Heart Failure and Cardiovascular Outcomes..  11:-. 2018
• Association Between Regional Adipose Tissue Distribution and Risk of Heart Failure Among Blacks..  11:-. 2018
• Lessons From the First 202 REHAB-HF Participants..  11:-. 2018
• Physical Function, Frailty, Cognition, Depression, and Quality of Life in Hospitalized Adults ≥60 Years With Acute Decompensated Heart Failure With Preserved Versus Reduced Ejection Fraction..  11:-. 2018
• IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction..  11:-. 2018
• Left Ventricular Mass Change After Anthracycline Chemotherapy..  11:-. 2018
• Association of Biomarker Clusters With Cardiac Phenotypes and Mortality in Patients With HIV Infection..  11:-. 2018
• Long-Term Cognitive Decline After Newly Diagnosed Heart Failure: Longitudinal Analysis in the CHS (Cardiovascular Health Study)..  11:-. 2018
• Contemporary Epidemiology of Heart Failure in Fee-For-Service Medicare Beneficiaries Across Healthcare Settings..  10. 2017
• Impact of Incident Heart Failure on Body Composition Over Time in the Health, Aging, and Body Composition Study Population..  10. 2017
• Association of Concentric Left Ventricular Hypertrophy With Subsequent Change in Left Ventricular End-Diastolic Volume: The Dallas Heart Study..  10. 2017
• Making the Case for Skeletal Muscle Myopathy and Its Contribution to Exercise Intolerance in Heart Failure With Preserved Ejection Fraction..  10. 2017
• Abnormal Global Longitudinal Strain Predicts Future Deterioration of Left Ventricular Function in Heart Failure Patients With a Recovered Left Ventricular Ejection Fraction..  10. 2017
• Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort Study..  10. 2017
• Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial..  10. 2017
• Reassessing Phase II Heart Failure Clinical Trials: Consensus Recommendations..  10. 2017
• Patient and Spousal Health and Outcomes in Heart Failure..  10. 2017
• Variation in Hospital Use and Outcomes Associated With Pulmonary Artery Catheterization in Heart Failure in the United States..  9. 2016
• Association of Weight and Body Composition on Cardiac Structure and Function in the ARIC Study (Atherosclerosis Risk in Communities)..  9. 2016
• Validation and Comparison of Seven Mortality Prediction Models for Hospitalized Patients With Acute Decompensated Heart Failure..  9. 2016
• Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure: Rationale and Design of the Randomized Trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I)..  9. 2016
• Burden of Systolic and Diastolic Left Ventricular Dysfunction Among Hispanics in the United States: Insights From the Echocardiographic Study of Latinos..  9:-. 2016
• Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes..  9:-. 2016
• Association of Serum Erythropoietin With Cardiovascular Events, Kidney Function Decline, and Mortality: The Health Aging and Body Composition Study..  9:-. 2016
• Psychosocial Factors, Exercise Adherence, and Outcomes in Heart Failure Patients: Insights From Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)..  8:1044-51. 2015
• Efficacy and Safety of Exercise Training in Chronic Pulmonary Hypertension: Systematic Review and Meta-Analysis..  8:1032-43. 2015
• Evaluation of the Incremental Prognostic Utility of Increasingly Complex Testing in Chronic Heart Failure..  8:709-16. 2015
• Kansas City Cardiomyopathy Questionnaire Score Is Associated With Incident Heart Failure Hospitalization in Patients With Chronic Kidney Disease Without Previously Diagnosed Heart Failure: Chronic Renal Insufficiency Cohort Study..  8:702-8. 2015
• Prognostic significance of depression in blacks with heart failure: insights from Heart Failure: a Controlled Trial Investigating Outcomes of Exercise Training..  8:497-503. 2015
• Exercise training as therapy for heart failure: current status and future directions..  8:209-20. 2015
• Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials..  8:33-40. 2014
• Prospective study of the association between dispositional optimism and incident heart failure..  7:394-400. 2014
• Hospital variation in noninvasive positive pressure ventilation for acute decompensated heart failure..  7:427-33. 2014
• Clinical outcomes after continuous-flow left ventricular assist device: a systematic review..  7:1003-13. 2014
• Soluble ST2 in ambulatory patients with heart failure: Association with functional capacity and long-term outcomes..  6:1172-9. 2013
• Physical fitness and risk for heart failure and coronary artery disease..  6:627-34. 2013
• Modest increase in peak VO2 is related to better clinical outcomes in chronic heart failure patients: results from heart failure and a controlled trial to investigate outcomes of exercise training..  5:579-85. 2012
• Cardiac microinjury measured by troponin T predicts collagen metabolism in adults aged >=65 years with heart failure..  5:406-13. 2012
• Frailty and the selection of patients for destination therapy left ventricular assist device..  5:286-93. 2012
• Short and precise patient self-assessment of heart failure symptoms using a computerized adaptive test..  5:331-9. 2012
• Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the HF-ACTION predictive risk score model..  5:63-71. 2011
• Validation of the health ABC heart failure model for incident heart failure risk prediction: the Cardiovascular Health Study..  3:495-502. 2010
• Recent national trends in readmission rates after heart failure hospitalization..  3:97-103. 2009
• Lipoprotein-associated phospholipase A(2) and risk of congestive heart failure in older adults: the Cardiovascular Health Study..  2:429-36. 2009

Identity

International Standard Serial Number (ISSN)

• 1941-3297